Thomas Kimble

711 total citations
27 papers, 503 citations indexed

About

Thomas Kimble is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Microbiology. According to data from OpenAlex, Thomas Kimble has authored 27 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 9 papers in Reproductive Medicine and 8 papers in Microbiology. Recurrent topics in Thomas Kimble's work include Reproductive Health and Contraception (11 papers), Reproductive tract infections research (8 papers) and Maternal and fetal healthcare (6 papers). Thomas Kimble is often cited by papers focused on Reproductive Health and Contraception (11 papers), Reproductive tract infections research (8 papers) and Maternal and fetal healthcare (6 papers). Thomas Kimble collaborates with scholars based in United States, Thailand and Ireland. Thomas Kimble's co-authors include David F. Archer, Andrea R. Thurman, Laurel Stadtmauer, Jill L. Schwartz, Gustavo F. Doncel, Intira Sriprasert, Sharon M. Anderson, Betsy C. Herold, Pedro M. M. Mesquita and Tina D. Cunningham and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Obstetrics and Gynecology and Fertility and Sterility.

In The Last Decade

Thomas Kimble

25 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kimble United States 12 228 217 108 98 71 27 503
Rebeca Massai United States 15 516 2.3× 239 1.1× 80 0.7× 95 1.0× 167 2.4× 19 703
Mathias Gysler Canada 12 326 1.4× 388 1.8× 46 0.4× 43 0.4× 113 1.6× 18 614
Ali Ulvi Hakverdi Türkiye 11 142 0.6× 99 0.5× 64 0.6× 85 0.9× 68 1.0× 28 338
Kaisa Elomaa Finland 10 206 0.9× 79 0.4× 60 0.6× 29 0.3× 52 0.7× 18 333
Mario Franchini Italy 14 104 0.5× 178 0.8× 39 0.4× 290 3.0× 84 1.2× 42 501
S Ramsewak Trinidad and Tobago 12 103 0.5× 104 0.5× 37 0.3× 84 0.9× 77 1.1× 53 405
Emery Wilson United States 8 192 0.8× 143 0.7× 47 0.4× 61 0.6× 94 1.3× 13 348
Muhammad Abdul Jamil Malaysia 13 173 0.8× 37 0.2× 24 0.2× 154 1.6× 150 2.1× 23 409
Leon R. Spadoni United States 12 268 1.2× 258 1.2× 76 0.7× 105 1.1× 94 1.3× 20 583
J D Wilson United Kingdom 9 101 0.4× 56 0.3× 315 2.9× 26 0.3× 23 0.3× 15 566

Countries citing papers authored by Thomas Kimble

Since Specialization
Citations

This map shows the geographic impact of Thomas Kimble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kimble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kimble more than expected).

Fields of papers citing papers by Thomas Kimble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kimble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kimble. The network helps show where Thomas Kimble may publish in the future.

Co-authorship network of co-authors of Thomas Kimble

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kimble. A scholar is included among the top collaborators of Thomas Kimble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kimble. Thomas Kimble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Beatrice A., et al.. (2023). Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use. Obstetrics and Gynecology. 141(5). 1004–1006. 1 indexed citations
2.
Kimble, Thomas, Anne E. Burke, Kurt T. Barnhart, et al.. (2020). A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen. SHILAP Revista de lepidopterología. 2. 100020–100020. 31 indexed citations
3.
Jensen, Jeffrey T., et al.. (2020). BLEEDING PATTERNS FROM MONTHS 60 TO 72 WITH USE OF A LEVONORGESTREL 52 MG INTRAUTERINE SYSTEM. Fertility and Sterility. 114(3). e11–e11.
4.
Chen, Beatrice A., Diana Blithe, Bruce R. Carr, et al.. (2019). Acceptability of the Woman's Condom in a phase III multicenter open-label study. Contraception. 99(6). 357–362. 7 indexed citations
5.
Liu, James, David E. Soper, Andrea S. Lukes, et al.. (2018). Ulipristal Acetate for Treatment of Uterine Leiomyomas. Obstetrics and Gynecology. 132(5). 1241–1251. 30 indexed citations
6.
Teal, Stephanie, et al.. (2018). Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System. Obstetrics and Gynecology. 133(1). 63–70. 30 indexed citations
7.
Sriprasert, Intira, et al.. (2017). Heavy menstrual bleeding diagnosis and medical management. SHILAP Revista de lepidopterología. 2(1). 20–20. 45 indexed citations
8.
Thurman, Andrea R., Nazita Yousefieh, Neelima Chandra, et al.. (2017). Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women. AIDS Research and Human Retroviruses. 33(8). 807–819. 31 indexed citations
9.
10.
Mauck, Christine, Vivian Brache, Thomas Kimble, et al.. (2017). A phase I randomized postcoital testing and safety study of the Caya diaphragm used with 3% Nonoxynol-9 gel, ContraGel or no gel. Contraception. 96(2). 124–130. 11 indexed citations
11.
Soper, David E., Andrea S. Lukes, Thomas Kimble, et al.. (2017). Ulipristal acetate (UPA) treatment of symptomatic uterine fibroids (UF): VENUS II subgroup analyses by race and BMI. Fertility and Sterility. 108(3). e28–e28. 1 indexed citations
12.
Thurman, Andrea R., Terry A. Jacot, Johan H. Melendez, et al.. (2016). Assessment of the vaginal residence time of biomarkers of semen exposure. Contraception. 94(5). 512–520. 16 indexed citations
13.
Thurman, Andrea R., Neelima Chandra, Nazita Yousefieh, et al.. (2016). Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women. AIDS Research and Human Retroviruses. 32(6). 547–560. 24 indexed citations
14.
Thurman, Andrea R., Thomas Kimble, Betsy C. Herold, et al.. (2015). Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity. AIDS Research and Human Retroviruses. 31(11). 1139–1152. 67 indexed citations
15.
Thurman, Andrea R., Terry A. Jacot, Thomas Kimble, et al.. (2014). Comparison of Visual and Ultraviolet Light Inspection Versus DNA/Protein Biomarkers to Assess Product Adherence With Vaginal Microbicide Applicators. Sexually Transmitted Diseases. 41(12). 739–746. 6 indexed citations
16.
Thurman, Andrea R., Thomas Kimble, Peter E. Hall, Jill L. Schwartz, & David F. Archer. (2012). Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics. Contraception. 87(6). 738–743. 13 indexed citations
17.
Kimble, Thomas, Andrea R. Thurman, & Jill L. Schwartz. (2011). Currently available combined oral contraception. Expert Review of Obstetrics & Gynecology. 6(5). 525–538. 4 indexed citations
18.
19.
Duran, E. Hakan, et al.. (2008). Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. American Journal of Obstetrics and Gynecology. 199(2). 202.e1–202.e8. 67 indexed citations
20.
Zhao, Shumei, et al.. (2008). Effects of progesterone, levonorgestrel and medroxyprogesterone acetate on apoptosis in human endometrial endothelial cells. Contraception. 79(2). 139–145. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebeca Massai Breakdown of academic impact, for papers by Mathias Gysler Breakdown of academic impact, for papers by Ali Ulvi Hakverdi Breakdown of academic impact, for papers by Kaisa Elomaa Breakdown of academic impact, for papers by Mario Franchini Breakdown of academic impact, for papers by S Ramsewak Breakdown of academic impact, for papers by Emery Wilson Breakdown of academic impact, for papers by Muhammad Abdul Jamil Breakdown of academic impact, for papers by Leon R. Spadoni Breakdown of academic impact, for papers by J D Wilson
Rankless by CCL
2026